Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
G-Quadruplex Modulation of TDP-43 Aggregation and Toxicity
2026-05-13
Oldani et al. reveal that RNA G-quadruplexes directly influence TDP-43 condensation and toxicity across multiple cellular models. This mechanistic insight suggests a new avenue for targeting protein aggregation in neurodegenerative diseases by modulating RNA secondary structures.
-
Grazoprevir hydrate: Precision HCV NS3/4A Protease Inhibitio
2026-05-13
Grazoprevir hydrate (MK-5172 hydrate) is a direct-acting antiviral that targets the hepatitis C virus NS3/4A protease with picomolar potency. Its robust efficacy extends to multiple HCV genotypes, with demonstrated clinical utility in complex patient groups. This article consolidates evidence, protocol guidance, and clarifies the compound's applications and boundaries.
-
Translational Apoptosis Detection: Mechanistic Insights, Str
2026-05-12
This thought-leadership article explores the mechanistic and translational significance of apoptosis detection, bridging the latest discoveries in cell death regulation with advanced assay technologies. Leveraging the One-step TUNEL Cy5 Apoptosis Detection Kit from APExBIO, the discussion provides strategic guidance for researchers seeking to optimize programmed cell death research in tissue sections and cultured cells, while integrating recent findings on immunometabolic regulation and cross-domain relevance.
-
PK/PD Insights on Gamithromycin for Rabbit Pasteurellosis Co
2026-05-12
This study delivers a comprehensive pharmacokinetic and pharmacodynamic (PK/PD) evaluation of gamithromycin against Pasteurella multocida in rabbits, revealing high subcutaneous bioavailability and concentration-dependent bactericidal activity. The findings clarify dosing strategies and highlight PK/PD index thresholds for therapeutic and eradication outcomes, providing a rational basis for antibiotic regimen design in veterinary infectious disease models.
-
HSBP7-Mediated Rescue in Titin Cardiomyopathy via Morphologi
2026-05-11
This study introduces a robust morphological imaging platform (CARDIO) to systematically uncover genetic modifiers of cardiomyocyte function in titin mutation-driven dilated cardiomyopathy. The key discovery is that HSPB7 loss paradoxically restores contractile function in titin-deficient cardiac cells, providing new insight into heart failure mechanisms and potential therapeutic targets.
-
Grazoprevir Hydrate: Precision Workflows for HCV Replication
2026-05-11
Grazoprevir hydrate (MK-5172 hydrate) delivers ultrapotent, reproducible inhibition of hepatitis C virus replication across challenging genotypes and comorbid conditions. This article details experimental protocols, troubleshooting, and advanced applications, translating recent peer-reviewed insights into actionable strategies for bench scientists.
-
Phosbind Acrylamide: Precision Phosphorylation Detection in
2026-05-10
Phosbind Acrylamide empowers researchers to resolve phosphorylation-dependent mobility shifts without phospho-specific antibodies, streamlining protein phosphorylation analysis. This advanced phosphate-binding reagent enhances experimental reproducibility and sensitivity in signaling pathway research, including neuropharmacological studies of social hierarchy and addiction.
-
Dorsomorphin (Compound C): Reliable AMPK/BMP Inhibition in C
2026-05-09
This article offers an evidence-driven, scenario-based guide to deploying Dorsomorphin (Compound C) (SKU B3252) for precise AMPK pathway inhibition and BMP4/Smad signaling studies. We address common laboratory challenges—ranging from protocol reproducibility to vendor reliability—supporting biomedical researchers with best practices grounded in recent literature and product specifications.
-
Hyperthermia Sensitizes BRCA2-Proficient Ovarian Cancer to P
2026-05-08
Mei et al. (2025) reveal that hyperthermia-induced reduction of BRCA2 protein can sensitize BRCA2-proficient ovarian carcinoma cells to PARP inhibitor treatment. This discovery provides a mechanistically supported strategy for overcoming intrinsic PARPi resistance in a substantial subset of ovarian cancers, with direct implications for combination therapy design.
-
Cyclophilin A Loss Confers Cyclosporine Resistance in Mice
2026-05-08
This study establishes that cyclophilin A (CypA) is essential for cyclosporine-mediated immunosuppression in mice. By demonstrating that CypA-deficient immune cells and animals are resistant to cyclosporine but not necessarily to other calcineurin inhibitors, this work clarifies the molecular specificity underlying immunosuppressive drug action and informs the selection of research tools in transplantation and autoimmune disease models.
-
AGO1 Regulates Stemness via Protein Folding in mESC Fate Dec
2026-05-07
This study uncovers an RNA-independent function for AGO1 in mouse embryonic stem cells (mESCs), showing that it maintains pluripotency by facilitating protein folding through HOP interaction. The findings distinguish AGO1’s mechanism from AGO2 and highlight novel regulatory layers in stem cell fate control, informing improved strategies for pluripotency maintenance and differentiation.
-
Selective Spectrophotometric Quantification of Phenolic β-La
2026-05-07
This article examines the development and validation of two selective spectrophotometric methods for the quantitative analysis of phenolic β-lactam antibiotics, including amoxicillin, cefoperazone, cefadroxil, and cefprozil. The innovation lies in rapid, cost-effective assays suitable for routine quality control and research, even in the presence of structurally related penicillins such as dicloxacillin.
-
G418 Sulfate (Geneticin): Precision Selection and Antiviral
2026-05-06
G418 Sulfate (Geneticin) is more than a classic selection antibiotic—its dual action as a rigorous genetic engineering tool and an emerging antiviral agent sets it apart in modern research. This article unpacks workflow best practices, advanced applications, and troubleshooting strategies to maximize reliability and experimental success with APExBIO's ultra-pure Geneticin, G-418 Sulfate.
-
Salinomycin: Polyether Ionophore Antibiotic for HCC Research
2026-05-06
Salinomycin, a polyether ionophore antibiotic, uniquely targets hepatocellular carcinoma via disruption of ABC drug transporters and the Wnt/β-catenin pathway. This article delivers actionable, data-driven workflows for maximizing assay reproducibility and overcoming common experimental challenges in cancer cell apoptosis research.
-
Intra- and Extracellular Dicloxacillin Activity Against MSSA
2026-05-05
This study rigorously compares the intra- and extracellular antimicrobial efficacy of dicloxacillin against MSSA using both in vitro human macrophage and in vivo mouse peritonitis models. By integrating pharmacokinetic-pharmacodynamic (PK/PD) analysis, the paper identifies key determinants of antibiotic response, supporting more precise experimental and therapeutic approaches.